Public Health Wales currently have Seegene platforms which are essential in providing a core part of NHS Wales COVID and respiratory testing, multiplex testing that includes Flu A, Flu B, RSV and SARS-CoV-2 and provide the largest multiplex testing capacity. The consumables included in this contract are essential for completing this testing and would have a significant impact on the service if not awarded.

The proposed direct call off contract will be established for a two-year term to maintain business continuity through to the end of the life of the analysers. It has been confirmed that Mast Group Ltd is the officially appointed agent in the UK for Seegene, and the risks associated with Mast not being awarded this contract will have significant impact on the service